These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11081891)

  • 1. Plasma concentrations of soluble tumor necrosis factor receptor I and tumor necrosis factor during cardiopulmonary bypass.
    Marano CW; Garulacan LA; Laughlin KV; Igidbashian L; Trace C; Goldman SM; Sutter FP; Reichard GA; Mullin JM
    Ann Thorac Surg; 2000 Oct; 70(4):1313-8. PubMed ID: 11081891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble tumor necrosis factor receptor p55 predicts cytokinemia and systemic inflammatory response after cardiopulmonary bypass.
    el-Barbary M; Khabar KS
    Crit Care Med; 2002 Aug; 30(8):1712-6. PubMed ID: 12163781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory cytokines and soluble receptors after coronary artery bypass grafting.
    Wei M; Kuukasjärvi P; Laurikka J; Pehkonen E; Kaukinen S; Laine S; Tarkka M
    Cytokine; 2001 Aug; 15(4):223-8. PubMed ID: 11563882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
    van Bommel EF; Hesse CJ; Jutte NH; Zietse R; Bruining HA; Weimar W
    Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass.
    Gormley SM; McBride WT; Armstrong MA; McClean E; MacGowan SW; Campalani G; McMurray TJ
    Cytokine; 2002 Jan; 17(2):61-5. PubMed ID: 11886172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further observations on the fetal inflammatory response syndrome: a potential homeostatic role for the soluble receptors of tumor necrosis factor alpha.
    Romero R; Maymon E; Pacora P; Gomez R; Mazor M; Yoon BH; Berry SM
    Am J Obstet Gynecol; 2000 Nov; 183(5):1070-7. PubMed ID: 11084543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preconditioning up-regulates the soluble TNF receptor I response to endotoxin.
    Wang M; Meng X; Tsai B; Wang JF; Turrentine M; Brown JW; Meldrum DR
    J Surg Res; 2004 Sep; 121(1):20-4. PubMed ID: 15313370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of systemic proinflammatory cytokines after off-pump versus conventional coronary artery bypass grafting.
    Schulze C; Conrad N; Schütz A; Egi K; Reichenspurner H; Reichart B; Wildhirt SM
    Thorac Cardiovasc Surg; 2000 Dec; 48(6):364-9. PubMed ID: 11145406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changes and effects of the plasma levels of tumor necrosis factor after coronary artery bypass surgery with cardiopulmonary bypass.
    Abacilar F; Dogan OF; Duman U; Ucar I; Demircin M; Ersoy U; Dogan R; Boke E
    Heart Surg Forum; 2006; 9(4):E703-9. PubMed ID: 16844625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia.
    Visser W; Beckmann I; Knook MA; Wallenburg HC
    Acta Obstet Gynecol Scand; 2002 Aug; 81(8):713-9. PubMed ID: 12174154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients.
    Warzocha K; Bienvenu J; Ribeiro P; Moullet I; Dumontet C; Neidhardt-Berard EM; Coiffier B; Salles G
    Br J Cancer; 1998 Jun; 77(12):2357-62. PubMed ID: 9649158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentrations of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in patients with anorexia nervosa.
    Nakai Y; Hamagaki S; Takagi R; Taniguchi A; Kurimoto F
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1226-8. PubMed ID: 10199758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma patterns of tumor necrosis factor-alpha (TNF) and TNF soluble receptors during acute meningococcal infections and the effect of plasma exchange.
    van Deuren M; Frieling JT; van der Ven-Jongekrijg J; Neeleman C; Russel FG; van Lier HJ; Bartelink AK; van der Meer JW
    Clin Infect Dis; 1998 Apr; 26(4):918-23. PubMed ID: 9564476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble tumor necrosis factor-alpha (TNF-alpha) receptors in human colostrum and milk bind to TNF-alpha and neutralize TNF-alpha bioactivity.
    Buescher ES; McWilliams-Koeppen P
    Pediatr Res; 1998 Jul; 44(1):37-42. PubMed ID: 9667368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
    Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
    Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifaceted inhibition of anti-tumour immune mechanisms by soluble tumour necrosis factor receptor type I.
    Selinsky CL; Boroughs KL; Halsey WA; Howell MD
    Immunology; 1998 May; 94(1):88-93. PubMed ID: 9708191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
    Núñez-González JR; Sanabria-Vera CJ; Romero-Adrián T
    Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dynamic change of tumor necrosis factor and endothelin during perioperative period in patients undergoing coronary artery bypass grafting].
    Wen S; Wang J; Zhang C
    Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(23):1450-2. PubMed ID: 11930620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass.
    Wan S; DeSmet JM; Barvais L; Goldstein M; Vincent JL; LeClerc JL
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):806-11. PubMed ID: 8800171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.